The World Health Organization says Zika won’t succumb to a quick fix, even as scientists move forward on new ways of stamping it out.
In a letter to the president, advisers say an “exponential” increase in biotechnology has created powerful tools that terrorists could exploit.
A clinical trial in China aims to see if engineered immune cells can fight off late-stage lung cancer.
Funding for the NIH has had bipartisan support, but Trump has called the agency “terrible.”
Male contraception research is a field littered with failures, but a few promising candidates are in the pipeline.
A step toward repairing spinal cord injury with electronics.
A trial meant to control the spread of Zika virus in the U.S. could be delayed.
Synthetic biologists are developing genetically modified bacteria that you swallow, but no one knows yet how they should be regulated.
People and dogs share some cancer-causing genetic mutations. Now the government is funding an effort to learn from that.
A needleless, remote-controlled device for tissue expansion is awaiting FDA approval.